Table 1.

Patients demographics

	100 μg	200 μg
No. patients enrolled	13	12
Sex
Male	13	11
Female	0	1
Age
Median	69	64.5
Range	49-72	53-79
Prior therapy
Surgery	6	5
Radiotherapy	11	7
Chemotherapy	13	12
Pre-existing antibody to NY-ESO-1 antigen	3	7
No. vaccinations
Median	8	9.5
Range	2-27	3-21